Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537)

Muhammad Usman Mirza; Atefeh Saadabadi; Michiel Vanmeert; Outi M.H. Salo-Ahen; Iskandar Abdullah; Sandra Claes; Steven De Jonghe; Dominique Schols; Sarfraz Ahmad; Matheus Froeyen

doi:10.1016/j.ejps.2021.105827

Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537)

Muhammad Usman Mirza, Atefeh Saadabadi, Michiel Vanmeert, Outi M.H. Salo-Ahen, Iskandar Abdullah, Sandra Claes, Steven De Jonghe, Dominique Schols, Sarfraz Ahmad, Matheus Froeyen^*

^*Tämän työn vastaava kirjoittaja

Tutkimustuotos: Muu myötävaikuttaminen › vertaisarvioitu

1 Sitaatiot (Scopus)

Abstrakti

The authors regret that the Acknowledgements section was missing from the original published version of the article. Acknowledgement should have been published as below.

Alkuperäiskieli	Englanti
Vuosikerta	162
DOI - pysyväislinkit	https://doi.org/10.1016/j.ejps.2021.105827
Tila	Julkaistu - 1 heinäk. 2021
OKM-julkaisutyyppi	O2 Other

Julkaisusarja

Nimi	European Journal of Pharmaceutical Sciences
Kustantaja	Elsevier
ISSN (painettu)	0928-0987

Pääsy asiakirjaan

10.1016/j.ejps.2021.105827

Muut tiedostot ja linkit

Linkki julkaisuun Scopuksessa

Sormenjälki

Sukella tutkimusaiheisiin 'Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537)'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.

Viittausmuodot

Mirza, M. U., Saadabadi, A., Vanmeert, M., Salo-Ahen, O. M. H., Abdullah, I., Claes, S., De Jonghe, S., Schols, D., Ahmad, S., & Froeyen, M. (2021, heinä 1). Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537). https://doi.org/10.1016/j.ejps.2021.105827

Mirza, Muhammad Usman ; Saadabadi, Atefeh ; Vanmeert, Michiel et al. / Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537). 2021. (European Journal of Pharmaceutical Sciences).

@misc{20c74df4670943039e04de6c94db5ba0,

title = "Corrigendum to {\textquoteleft}Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach{\textquoteright} [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537)",

abstract = "The authors regret that the Acknowledgements section was missing from the original published version of the article. Acknowledgement should have been published as below.",

author = "Mirza, {Muhammad Usman} and Atefeh Saadabadi and Michiel Vanmeert and Salo-Ahen, {Outi M.H.} and Iskandar Abdullah and Sandra Claes and {De Jonghe}, Steven and Dominique Schols and Sarfraz Ahmad and Matheus Froeyen",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier B.V.",

year = "2021",

month = jul,

day = "1",

doi = "10.1016/j.ejps.2021.105827",

language = "English",

volume = "162",

series = "European Journal of Pharmaceutical Sciences",

publisher = "Elsevier",

type = "Other",

}

Mirza, MU, Saadabadi, A, Vanmeert, M, Salo-Ahen, OMH, Abdullah, I, Claes, S, De Jonghe, S, Schols, D, Ahmad, S & Froeyen, M 2021, Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537).. https://doi.org/10.1016/j.ejps.2021.105827

Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537). / Mirza, Muhammad Usman; Saadabadi, Atefeh; Vanmeert, Michiel et al.
2021. (European Journal of Pharmaceutical Sciences).

Tutkimustuotos: Muu myötävaikuttaminen › vertaisarvioitu

TY - GEN

T1 - Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537)

AU - Mirza, Muhammad Usman

AU - Saadabadi, Atefeh

AU - Vanmeert, Michiel

AU - Salo-Ahen, Outi M.H.

AU - Abdullah, Iskandar

AU - Claes, Sandra

AU - De Jonghe, Steven

AU - Schols, Dominique

AU - Ahmad, Sarfraz

AU - Froeyen, Matheus

PY - 2021/7/1

Y1 - 2021/7/1

N2 - The authors regret that the Acknowledgements section was missing from the original published version of the article. Acknowledgement should have been published as below.

AB - The authors regret that the Acknowledgements section was missing from the original published version of the article. Acknowledgement should have been published as below.

UR - http://www.scopus.com/inward/record.url?scp=85103592235&partnerID=8YFLogxK

U2 - 10.1016/j.ejps.2021.105827

DO - 10.1016/j.ejps.2021.105827

M3 - Other contribution

C2 - 33814256

AN - SCOPUS:85103592235

VL - 162

T3 - European Journal of Pharmaceutical Sciences

ER -